NZ511832A - Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester - Google Patents

Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester

Info

Publication number
NZ511832A
NZ511832A NZ511832A NZ51183299A NZ511832A NZ 511832 A NZ511832 A NZ 511832A NZ 511832 A NZ511832 A NZ 511832A NZ 51183299 A NZ51183299 A NZ 51183299A NZ 511832 A NZ511832 A NZ 511832A
Authority
NZ
New Zealand
Prior art keywords
composition
composition according
glucocorticoid
hydrocortisone
propylene glycol
Prior art date
Application number
NZ511832A
Other languages
English (en)
Inventor
Gunilla Lekare
Original Assignee
Medivir Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20413320&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NZ511832(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Medivir Ab filed Critical Medivir Ab
Publication of NZ511832A publication Critical patent/NZ511832A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NZ511832A 1998-11-18 1999-11-12 Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester NZ511832A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9803929A SE9803929D0 (sv) 1998-11-18 1998-11-18 Antiviral formulation
PCT/SE1999/002043 WO2000029027A1 (en) 1998-11-18 1999-11-12 Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester

Publications (1)

Publication Number Publication Date
NZ511832A true NZ511832A (en) 2003-09-26

Family

ID=20413320

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ511832A NZ511832A (en) 1998-11-18 1999-11-12 Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester

Country Status (21)

Country Link
EP (1) EP1131104B1 (enExample)
JP (2) JP2002529520A (enExample)
KR (1) KR100608963B1 (enExample)
CN (1) CN1160128C (enExample)
AR (1) AR023705A1 (enExample)
AT (1) ATE288283T1 (enExample)
AU (1) AU772435B2 (enExample)
CA (1) CA2351463C (enExample)
DE (1) DE69923584T2 (enExample)
DK (1) DK1131104T3 (enExample)
EG (1) EG23853A (enExample)
ES (1) ES2233104T3 (enExample)
HK (1) HK1042440B (enExample)
IL (2) IL142702A0 (enExample)
MY (1) MY122397A (enExample)
NZ (1) NZ511832A (enExample)
PT (1) PT1131104E (enExample)
SE (1) SE9803929D0 (enExample)
TW (1) TW589191B (enExample)
WO (1) WO2000029027A1 (enExample)
ZA (1) ZA200103335B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100956369B1 (ko) * 2001-11-19 2010-05-10 메디진 아게 바이러스성 피부 질환 및 종양 질환 치료용 약제
ZA200602544B (en) 2003-10-09 2007-06-27 Medigene Ag The use of a polyphenol for the treatment of a cancerous or pre-cancerous lesion of the skin
JP4972062B2 (ja) * 2008-03-17 2012-07-11 メディヴィル・アクチエボラーグ 抗ウイルス製剤
ES2955089T3 (es) * 2018-08-17 2023-11-28 Ilko Ilac Sanayi Ve Ticaret Anonim Sirketi Composición tópica estable en fase que comprende aciclovir e hidrocortisona

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW438585B (en) * 1995-02-06 2001-06-07 Astra Ab Pharmaceutical compositions for topical administration for prophylaxis and/or treatment of herpesvirus infections
US5760096A (en) * 1996-10-18 1998-06-02 Thornfeldt; Carl R. Potent penetration enhancers

Also Published As

Publication number Publication date
HK1042440A1 (en) 2002-08-16
EG23853A (en) 2007-11-06
AU1436400A (en) 2000-06-05
AU772435B2 (en) 2004-04-29
TW589191B (en) 2004-06-01
CN1326364A (zh) 2001-12-12
DK1131104T3 (da) 2005-03-14
ES2233104T3 (es) 2005-06-01
IL142702A (en) 2006-07-05
HK1042440B (zh) 2005-04-29
EP1131104B1 (en) 2005-02-02
ZA200103335B (en) 2002-07-24
MY122397A (en) 2006-04-29
ATE288283T1 (de) 2005-02-15
CN1160128C (zh) 2004-08-04
CA2351463C (en) 2009-10-13
DE69923584T2 (de) 2006-03-23
JP2002529520A (ja) 2002-09-10
IL142702A0 (en) 2002-03-10
KR20010075720A (ko) 2001-08-09
PT1131104E (pt) 2005-03-31
EP1131104A1 (en) 2001-09-12
WO2000029027A1 (en) 2000-05-25
JP5420583B2 (ja) 2014-02-19
SE9803929D0 (sv) 1998-11-18
CA2351463A1 (en) 2000-05-25
AR023705A1 (es) 2002-09-04
JP2011157392A (ja) 2011-08-18
KR100608963B1 (ko) 2006-08-09
DE69923584D1 (de) 2005-03-10

Similar Documents

Publication Publication Date Title
EP0044543B1 (en) Topical formulations of 9-(2-hydroxyethoxymethyl) guanine
WO1996002244A1 (en) A topical preparation for the prevention and treatment of lesions and sores associated with a herpes virus
US4963555A (en) Formulations of heterocyclic compounds
US20170020882A1 (en) Antiviral formulation
US7223387B2 (en) Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester
WO1998010768A1 (en) Antiviral compositions
WO1997034607A1 (en) Topical formulations of aciclovir
JP5420583B2 (ja) プロピレングリコールおよびアルカン酸イソプロピルエステルを含む抗ウイルス製剤
EP3836934B1 (en) Phase stable topical composition comprising acyclovir and hydrocortisone
MXPA01005020A (en) Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester
SA99200836B1 (ar) صيغ مضادة للفيروسات antiviral formulations تتضمن propylene glycol واستر أيزويروبيلي لحمض الكانوي isopropyl alkanoic acid ester
EP0787490A1 (en) A topical preparation for the prevention and treatment of lesions and sores associated with a herpes virus
SK279096B6 (sk) Liečivá masť bez dráždivého účinku na kožu
TR2021002170T2 (tr) Faz ayrişmasi olmayan asi̇klovi̇r ve hi̇drokorti̇zon i̇çeren topi̇kal formülasyon
MXPA01006490A (en) Aciclovir compositions containing dimethicone

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
EXPY Patent expired